317 related articles for article (PubMed ID: 21834957)
1. Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.
Vintiñi EO; Medina MS
BMC Immunol; 2011 Aug; 12():46. PubMed ID: 21834957
[TBL] [Abstract][Full Text] [Related]
2. Safety of a nasal vaccine against Streptococcus pneumoniae using heat-killed Lactobacillus casei as adjuvant.
Almada G; Haro C; Vintiñi E; Medina M
Immunobiology; 2015 Jan; 220(1):109-16. PubMed ID: 25240632
[TBL] [Abstract][Full Text] [Related]
3. Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge.
Campos IB; Darrieux M; Ferreira DM; Miyaji EN; Silva DA; Arêas AP; Aires KA; Leite LC; Ho PL; Oliveira ML
Microbes Infect; 2008 Apr; 10(5):481-8. PubMed ID: 18403234
[TBL] [Abstract][Full Text] [Related]
4. Immune response in nasopharynx, lung, and blood elicited by experimental nasal pneumococcal vaccines containing live or heat-killed lactobacilli as mucosal adjuvants.
Vintiñi EO; Medina M
Can J Physiol Pharmacol; 2014 Feb; 92(2):124-31. PubMed ID: 24502635
[TBL] [Abstract][Full Text] [Related]
5. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
6. Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei.
Villena J; Barbieri N; Salva S; Herrera M; Alvarez S
Microbiol Immunol; 2009 Nov; 53(11):636-46. PubMed ID: 19903264
[TBL] [Abstract][Full Text] [Related]
7. Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice.
Hernani Mde L; Ferreira PC; Ferreira DM; Miyaji EN; Ho PL; Oliveira ML
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):263-72. PubMed ID: 21492260
[TBL] [Abstract][Full Text] [Related]
8. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
Oliveira ML; Arêas AP; Campos IB; Monedero V; Perez-Martínez G; Miyaji EN; Leite LC; Aires KA; Lee Ho P
Microbes Infect; 2006 Apr; 8(4):1016-24. PubMed ID: 16549380
[TBL] [Abstract][Full Text] [Related]
9. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
Laiño J; Villena J; Suvorov A; Zelaya H; Ortiz Moyano R; Salva S; Alvarez S
PLoS One; 2018; 13(11):e0206661. PubMed ID: 30395582
[TBL] [Abstract][Full Text] [Related]
10. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
Villena J; Medina M; Racedo S; Alvarez S
J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
[TBL] [Abstract][Full Text] [Related]
11. Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice.
Medina M; Villena J; Vintiñi E; Hebert EM; Raya R; Alvarez S
Infect Immun; 2008 Jun; 76(6):2696-705. PubMed ID: 18390997
[TBL] [Abstract][Full Text] [Related]
12. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
Villena J; Medina M; Raya R; Alvarez S
Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
[TBL] [Abstract][Full Text] [Related]
13. Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice.
Vintiñi E; Villena J; Alvarez S; Medina M
Clin Exp Immunol; 2010 Mar; 159(3):351-62. PubMed ID: 20002449
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.
Jakobsen H; Schulz D; Pizza M; Rappuoli R; Jónsdóttir I
Infect Immun; 1999 Nov; 67(11):5892-7. PubMed ID: 10531245
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.
Hvalbye BK; Aaberge IS; Løvik M; Haneberg B
Infect Immun; 1999 Sep; 67(9):4320-5. PubMed ID: 10456869
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
[TBL] [Abstract][Full Text] [Related]
18. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
19. Vaccination With the Commensal
Shekhar S; Åmdal HA; Petersen FC
Front Immunol; 2021; 12():676488. PubMed ID: 33953733
[TBL] [Abstract][Full Text] [Related]
20. Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.
Salcedo-Rivillas C; Debrie AS; Miyaji EN; Ferreira JM; Raw I; Locht C; Ho PL; Mielcarek N; Oliveira ML
Clin Vaccine Immunol; 2014 Jul; 21(7):972-81. PubMed ID: 24807055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
